Dr. Gurner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
295 Saint Johns Pl
No. 3b
Brooklyn, NY 11238Phone+1 917-628-1405
Education & Training
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1996 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1996
Certifications & Licensure
NY State Medical License 1997 - 2026
Publications & Presentations
PubMed
- 2 citationsMorphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.Kenneth G. Saag, Tobias J. de Villiers, Peter Alexandersen, Heidi Jacobe, Carrie L. Kovarik
Journal of the American Academy of Dermatology. 2021-04-01 - 38 citationsEffects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled T...Sydney Lou Bonnick, Tobias De Villiers, Alberto Odio, Santiago Palacios, Roland Chapurlat
The Journal of Clinical Endocrinology and Metabolism. 2013-09-24 - 51 citationsA randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaCarlos A. Camargo, Deborah M. Gurner, Howard A. Smithline, Rocio Chapela, Leonardo M. Fabbri
The Journal of Allergy and Clinical Immunology. 2010-02-01
Authored Content
- Incidence of Hypersensitivity and Anaphylaxis with SugammadexApril 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
